ES2052893T3 - Preparado de n-acetil-glucosamina para administracion por via bucal. - Google Patents

Preparado de n-acetil-glucosamina para administracion por via bucal.

Info

Publication number
ES2052893T3
ES2052893T3 ES89250020T ES89250020T ES2052893T3 ES 2052893 T3 ES2052893 T3 ES 2052893T3 ES 89250020 T ES89250020 T ES 89250020T ES 89250020 T ES89250020 T ES 89250020T ES 2052893 T3 ES2052893 T3 ES 2052893T3
Authority
ES
Spain
Prior art keywords
administration
acetyl
route
glucosamine
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89250020T
Other languages
English (en)
Inventor
Ulrich Dr Speck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Steigerwald Arzneimittelwerk GmbH
Original Assignee
Steigerwald Arzneimittelwerk GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/302,403 external-priority patent/US4870061A/en
Application filed by Steigerwald Arzneimittelwerk GmbH filed Critical Steigerwald Arzneimittelwerk GmbH
Application granted granted Critical
Publication of ES2052893T3 publication Critical patent/ES2052893T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

EL INVENTO SE REFIERE A LA APLICACION BUCAL DE N-ACETILGLUCOSAMINA PARA LA TERAPIA DEGENERATIVA, ENFERMEDADES INFLAMABLES DE LA ARTICULACION, TEJIDOS PROTECTORES Y LIGANTES Y ENFERMEDADES RELACIONADAS CON LOS TEJIDOS.
ES89250020T 1989-01-26 1989-08-28 Preparado de n-acetil-glucosamina para administracion por via bucal. Expired - Lifetime ES2052893T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/302,403 US4870061A (en) 1986-01-29 1989-01-26 Use of N-acetylglucosamine for the therapy of degenerative joint disease and related diseases

Publications (1)

Publication Number Publication Date
ES2052893T3 true ES2052893T3 (es) 1994-07-16

Family

ID=23167604

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89250020T Expired - Lifetime ES2052893T3 (es) 1989-01-26 1989-08-28 Preparado de n-acetil-glucosamina para administracion por via bucal.

Country Status (7)

Country Link
EP (1) EP0379753B1 (es)
JP (1) JPH07103033B2 (es)
AT (1) ATE82127T1 (es)
DE (2) DE3927723A1 (es)
ES (1) ES2052893T3 (es)
GR (1) GR3006815T3 (es)
WO (1) WO1990008549A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9003614L (sv) * 1990-11-13 1992-05-14 Kurt G I Nilsson Kosmetisk produkt
CN1067246C (zh) * 1996-12-27 2001-06-20 中国人民解放军第三军医大学 N－乙酰－d－氨基葡萄糖在制备治疗皮肤癣菌的药物中的应用
CN1095366C (zh) * 1996-12-27 2002-12-04 中国人民解放军第三军医大学 N－乙酰－d－氨基葡萄糖在制备治疗肠道疾病药物中的应用
CN1067245C (zh) * 1996-12-27 2001-06-20 中国人民解放军第三军医大学 N－乙酰－d－氨基葡萄糖在制备治疗呼吸道疾病的药物中的应用
US7273925B1 (en) 1998-12-15 2007-09-25 Brigham And Women's Hospital, Inc. Methods and products for regulating lectin complement pathway associated complement activation
CA2347734A1 (en) * 1998-12-15 2000-06-22 Brigham And Women's Hospital, Inc. Methods and products for regulating lectin complement pathway associated complement activation
AU2003227681A1 (en) * 2002-04-26 2003-11-10 Novartis Ag Method for treating inflammatory disorders
CN1533776A (zh) * 2003-03-27 2004-10-06 中国人民解放军第三军医大学 N-乙酰氨基葡萄糖在制备用于治疗病毒或细菌感染所致的局部损伤和全身症状的药物中的应用
CN1232257C (zh) 2003-03-27 2005-12-21 中国人民解放军第三军医大学 N－乙酰氨基葡萄糖在制备治疗和控制物理化学因素致非特异性炎症的药物中的应用
CN1232256C (zh) * 2003-03-27 2005-12-21 中国人民解放军第三军医大学 N－乙酰氨基葡萄糖在制备治疗自身免疫反应所致的局部损伤或全身症状的药物中的应用
JP2007507516A (ja) * 2003-10-01 2007-03-29 オプティマー・ファーマスーティカルズ・インコーポレイテッド アミノ糖投与による哺乳動物の障害の治療及びアミノ糖の使用
CA2546861A1 (en) * 2003-11-24 2005-06-09 Optimer Pharmaceuticals, Inc. Treatment of a condition in a mammal with administration of compounds and methods of use thereof
TWI354559B (en) * 2004-12-27 2011-12-21 Yaizu Suisankagaku Ind Co Ltd Oral disintegrative n-acetylglucosamine tablet and
US8524453B2 (en) 2006-02-10 2013-09-03 The Brigham And Woman's Hospital, Inc. Lectin complement pathway assays and related compositions and methods
JP5587543B2 (ja) * 2008-02-06 2014-09-10 サントリーホールディングス株式会社 グルコサミンを含有する経口投与用固形製剤
KR101098581B1 (ko) 2009-01-09 2011-12-26 서울대학교산학협력단 Ａｂｈ 항원을 이용한 염증질환 개선용 조성물
WO2010144943A1 (en) * 2009-05-20 2010-12-23 Ozpharma Pty Ltd Buccal and/or sublingual therapeutic formulation
JP6270362B2 (ja) * 2013-07-17 2018-01-31 日本水産株式会社 関節痛改善剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1792346C3 (de) * 1968-08-22 1980-10-23 Rotta Research Laboratorium S.P.A., San Fruttuoso Di Monza, Mailand (Italien) Pharmazeutisches Präparat für die Behandlung von degenerativen Gelenkerkrankungen
US4647453A (en) * 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
DE3602670A1 (de) * 1986-01-29 1987-07-30 Speck Ulrich Verwendung von n-acetylglucosamin zur therapie degenerativer gelenkprozesse und verwandter erkrankungen

Also Published As

Publication number Publication date
EP0379753B1 (de) 1992-11-11
EP0379753A1 (de) 1990-08-01
JPH07103033B2 (ja) 1995-11-08
DE3927723A1 (de) 1990-08-02
DE58902712D1 (de) 1992-12-17
ATE82127T1 (de) 1992-11-15
GR3006815T3 (es) 1993-06-30
WO1990008549A1 (de) 1990-08-09
JPH04502758A (ja) 1992-05-21

Similar Documents

Publication Publication Date Title
ES2052893T3 (es) Preparado de n-acetil-glucosamina para administracion por via bucal.
BG101118A (en) Therapeutical compounds
HK160995A (en) Complex compounds of bioflavonoids with phospholipids their preparation and use and pharmaceutical and cosmetic compositions containing them
DK0733067T3 (da) N-terminalt kemisk modificerede proteinpræparater og fremgangsmåder
BG103335A (en) Application of fumaric acid derivatives
BG104315A (en) Prostaglandine agonists and their application for the treatment of osteal diseases
BR9907995A (pt) Métodos imunológicos para modular miostatina em sujeitos vertebrados
HUT60512A (en) Process for producing polyethylene glycol conjugates of proteins
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
ES2163034T3 (es) Composiciones micelares de copolimeros de bloque de polieter, para la objetivizacion de agentes biologicos como diana.
AU561016B2 (en) N-glycosylated carboxamide derivatives
IL112667A0 (en) 6-substituted derivatives of mycophenolic acid, their preparation and pharmaceutical compositions containing them
NO972391L (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
IL94278A0 (en) 2-saccharine derivatives,their preparation and pharmaceutical compositions containing them
ES2144239T3 (es) Derivados de vitamina d con sustituyentes en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos.
FI913943A0 (fi) Nya kroman- och tiokromanderivat.
DK0500773T3 (da) Ikke-glycosyleret FGF-4 og præparater indeholdende dette
DK0482097T3 (da) Tensidpræparater og fremgangsmåder
ES2144054T3 (es) Complejos de tri(platino).
DK0387821T3 (da) 2-Alkyl-4-arylmethylchinoliner, deres anvendelse og lægemidler fremstillet hermed
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
NZ222434A (en) Tissue factor protein lacking its naturally associated phospholipid
DE68927055D1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
ATE93388T1 (de) Paracetamol enthaltende arzneizubereitung.
AU1174588A (en) Anticonvulsant agents

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 379753

Country of ref document: ES